HOME › DRUGS › SELEXIPAG
ACTIVE SUBSTANCE / INN

SELEXIPAG

Brand name(s): UPTRAVI, Uptravi, SELEXIPAG
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA214414
Hypertension, Pulmonary
ACTIVE SUBSTANCE
Selexipag
REGULATORS
FDA · EMA
SPONSORS / MAH
Janssen Cilag International NV, ZYDUS LIFESCIENCES, VGYAAN
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
UPTRAVINDA214275ACTELIONPrescription
SELEXIPAGANDA214055VGYAANNone (Tentative Approval)
SELEXIPAGANDA214302ZYDUS LIFESCIENCESDiscontinued
SELEXIPAGANDA214414ALEMBICPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
UptraviJanssen Cilag International NVAuthorised12/05/2016Hypertension, Pulmonary

FULL INTELLIGENCE ON SELEXIPAG

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →